Market cap
$3 Mln
Revenue (TTM)
$8 Mln
P/E Ratio
0
P/B Ratio
1.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-5.2 %
-
ROCE
-- %
-
Industry P/E
46.09
-
EV/EBITDA
-4.2
-
Debt to Equity
3.8
-
Book Value
$--
-
EPS
$-54.3
-
Face value
--
-
Shares outstanding
984,407
10 Years Aggregate
CFO
$-101.13 Mln
EBITDA
$-146.13 Mln
Net Profit
$-176.56 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Beyond Air (XAIR)
| -75.7 | -44.2 | -60.0 | -92.4 | -85.9 | -75.7 | -- |
|
BSE Sensex
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Beyond Air (XAIR)
| -89.9 | -81.5 | -69.8 | -31.3 | 79.1 | 0.8 | 12.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Beyond Air (XAIR)
|
3.5 | 3.5 | 7.7 | -33.5 | -348.7 | -648.9 | 0 | 1.8 |
| 62.7 | 8,162.7 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.0 | |
| 15.0 | 10,125.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.8 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.4 | |
| 58.5 | 8,913.0 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 177.5 | 10,637.8 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 15.3 | |
| 101.0 | 6,590.6 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.2 | 5.0 | |
| 89.6 | 5,350.1 | 1,579.2 | 145.6 | 14.3 | 8.9 | 36.9 | 3.2 | |
| 322.2 | 12,649.5 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.3 | 8.3 | |
| 167.6 | 9,458.6 | 785.1 | 41.5 | 9.9 | 2 | 232.8 | 4.6 |
Shareholding Pattern
View DetailsAbout Beyond Air (XAIR)
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension... of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-high concentration NO (UNO) that is in Phase 1 clinical trial to treat solid tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York. Read more
-
CEO & Chairman of the Board
Mr. Steven Adam Lisi
-
CEO & Chairman of the Board
Mr. Steven Adam Lisi
-
Headquarters
Garden City, NY
-
Website
FAQs for Beyond Air (XAIR)
What is the current share price of Beyond Air Inc (XAIR) Today?
The share price of Beyond Air Inc (XAIR) is $3.53 (NASDAQ) as of 04-Sep-2026 16:22 EDT. Beyond Air Inc (XAIR) has given a return of -85.93% in the last 3 years.
What is the current PB & PE ratio of Beyond Air Inc (XAIR)?
The P/E ratio of Beyond Air Inc (XAIR) is 0.01 times as on 04-Sep-2026, a 100 discount to its peers’ median range of 46.09 times.
The P/B ratio of Beyond Air Inc (XAIR) is 1.76 times as on 04-Sep-2026, a 54 discount to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
-0.17 |
0.94 |
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.01 |
2023 |
-3.72 |
4.94 |
2022 |
-3.97 |
2.19 |
What is the 52 Week High and Low of Beyond Air Inc (XAIR)?
The 52-week high and low of Beyond Air Inc (XAIR) are Rs 177.72 and Rs 3.50 as of 06-Sep-2026.
What is the market cap of Beyond Air Inc (XAIR)?
Beyond Air Inc (XAIR) has a market capitalisation of $ 3 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Beyond Air Inc (XAIR)?
Before investing in Beyond Air Inc (XAIR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.